Difference between revisions of "Team:Lethbridge/Part Collection"

Line 34: Line 34:
 
             <h2 class="segmentHeader">Part Design Overview</h2>
 
             <h2 class="segmentHeader">Part Design Overview</h2>
  
<p class="text12j">Each part in our collection was designed with several features in mind:</p>
+
<p class="text14">Each part in our collection was designed with several features in mind:</p>
<ul class="text12" style="list-style: disc">
+
    <ul class="text12" style="list-style: disc">
<li class="text12">Optimized for expression in <i>E. coli</i></li>
+
    <li class="text12">Optimized for expression in <i>E. coli</i></li>
<li class="text12">N- or C-terminal hexahistidine affinity tag</li>
+
    <li class="text12">N- or C-terminal hexahistidine affinity tag</li>
<li class="text12">Constructs contain the T7 promoter (<a href="http://partsregistry.org/Part:BBa_I719005" id="pageLink">BBa_I719005</a>), medium RBS (<a href="http://parts.igem.org/Part:BBa_B0034" id="pageLink">BBa_B0034</a>), and double terminator (<a href="http://parts.igem.org/Part:BBa_B0015" id="pageLink">BBa_B0015</a>)</li>
+
    <li class="text12">Constructs contain the T7 promoter (<a href="http://partsregistry.org/Part:BBa_I719005" id="pageLink">BBa_I719005</a>), medium RBS (<a href="http://parts.igem.org/Part:BBa_B0034" id="pageLink">BBa_B0034</a>), and double terminator (<a href="http://parts.igem.org/Part:BBa_B0015" id="pageLink">BBa_B0015</a>)</li>
 
</ul>
 
</ul>
  

Revision as of 22:25, 30 October 2017



Overview

The Next vivo system is made up of >40 unique parts encoding both protein.



Part Design Overview

Each part in our collection was designed with several features in mind:

  • Optimized for expression in E. coli
  • N- or C-terminal hexahistidine affinity tag
  • Constructs contain the T7 promoter (BBa_I719005), medium RBS (BBa_B0034), and double terminator (BBa_B0015)

Part Collection

The Next vivo system is made up of >40 unique parts encoding both protein and RNA components. The main focus of our team this year was to submit all 38 TX-TL protein components to the registry as a collection of parts that anyone could use to produce their own Next vivo system. Several of these TX-TL components were already in the registry but were under different expression control, lacked purification tags, and/or were not codon optimized for expression in E. coli. As such we sought to improve these parts for future use.



Future Use for iGEM



Our Parts in the Registry



<groupparts>iGEM2017 Lethbridge</groupparts>